查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576952

颅内动脉瘤:市场洞察·竞争环境·市场预测 (～2030年)

Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

颅内动脉瘤市场规模预计将从 2023 年的 11.3 亿美元增至 2030 年的 19 亿美元，在 2024-2030 年预测期内复合年增长率为 9.10%。

颅内动脉瘤市场正在经历显着的市场成长，这主要是由于高血压等慢性疾病的增加、主要参与者的创新产品开发活动、人口老龄化的扩大以及政府举措的增加。

颅内动脉瘤市场动态：

根据世界卫生组织 (WHO) 2023 年的数据，全球估计有 12.8 亿 30 岁至 79 岁的成年人患有高血压，并且生活在低收入和中等收入国家。高血压是颅内动脉瘤的重要危险因素，促使对有效诊断和治疗方案的需求不断增加，从而促使与颅内动脉瘤治疗相关的医疗设备和技术市场不断扩大。

根据世界卫生组织2021年数据，2015年至2050年间，60岁及以上人口数量将翻一番，从12%增至22%，预计2050年将达到21亿。此外，到 2030 年，六分之一的人将超过 60 岁。与年龄相关的健康问题（例如可导致颅内动脉瘤的脑血管疾病）日益普遍，需要先进的诊断和治疗方案。随着医疗保健系统投资于血管内治疗和技术以有效管理动脉瘤，这些人口变化正在推动市场成长。

根据颅内动脉瘤的产品类型，栓塞弹簧圈预计将在 2023 年占据很大的收入占有率。这是因为栓塞弹簧圈被广泛使用，并且具有多种关键特征，可以增强其实用性和有效性。

栓塞弹簧圈在颅内动脉瘤的微创治疗中非常重要，它具有高灵活性和 X 光下可视性等关键特性，可确保在动脉瘤内精确放置。这些线圈通常由铂製成，可膨胀以填充动脉瘤囊，从而诱导血块形成并降低破裂的风险。有些线圈涂有生物活性或水凝胶材料，以促进动脉瘤内的凝血和癒合。

按地区划分，北美地区预计将在 2023 年引领市场，并在预测期内表现出类似的地位。除了脑动脉瘤的高发生率之外，包括产品开发和监管审批方面的重大发展、市场中主要参与者的存在以及先进医疗基础设施的可用性在内的几个因素预计将在预计区域增长。

本报告提供全球颅内动脉瘤的市场调查，提供市场概要，市场影响因素及市场机会分析，法律制度，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 颅内动脉瘤市场:简介

第2章 颅内动脉瘤市场:摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 颅内动脉瘤市场:主要要素分析

  • 推动市场要素
    • 慢性疾病增加
    • 增加产品开发活动
    • 与生活方式相关的疾病增加
    • 人口老化加剧
  • 阻碍市场要素·课题
    • 严格的监理审批流程
    • 与颅内动脉瘤治疗装置相关的併发症
  • 市场机会
    • 生物可吸收材料的研究
    • 全球和区域製造商的策略性业务活动

第6章 颅内动脉瘤市场:波特的五力分析

第7章 颅内动脉瘤市场:市场评估

  • 各产品类型
    • 手术夹闭
    • 栓塞线圈
    • 分流器
    • 其他
  • 各终端用户
    • 医院
    • 门诊病人手术中心
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 颅内动脉瘤市场:企业·产品简介

  • Medtronic
  • MicroPort Scientific Corporation.
  • B. Braun Melsungen AG
  • Stryker
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
  • Penumbra, Inc.
  • Balt
  • Wallaby Medical
  • Shape Memory Medical Inc.
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • Spartan Micro, Inc.
  • Mizuho Medical Co. Ltd
  • Lepu Medical Technology Co., Ltd.
  • Phenox GmbH
  • Peter LAZIC GmbH
  • adeor medical AG
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • KANEKA CORPORATION

第9章 KOL的见解

第10章 计划方法

第11章 关于DelveInsight

第12章 免责声明·咨询方式

Product Code: DIMDCL0527

Intracranial Aneurysms Market by Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, and Others), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide

The intracranial aneurysms market was valued at USD 1.13 billion in 2023, growing at a CAGR of 9.10% during the forecast period from 2024 to 2030, to reach USD 1.90 billion by 2030. The intracranial aneurysms market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as hypertension, innovative product developmental activities by leading companies, expanding geriatric population, and increasing government initiatives that are factors expected to escalate the overall growth of the intracranial aneurysms market during the forecast period from 2024 to 2030.

Intracranial Aneurysms Market Dynamics:

As per data provided by the World Health Organization (WHO) (2023), it stated that an estimated 1.28 billion adults aged between 30 and 79 years worldwide had hypertension, living in low- and middle-income countries. High blood pressure or hypertension is a significant risk factor for intracranial aneurysms, leading to an increased demand for effective diagnostic and treatment options and thus resulting in a larger market for medical devices and technologies related to intracranial aneurysm treatment.

Data from the WHO 2021, stated that between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. Due to the higher prevalence of age-related health issues, including cerebrovascular diseases that can lead to intracranial aneurysms, necessitating advanced diagnostic and treatment options. This demographic shift is prompting healthcare systems to invest more in endovascular procedures and technologies to manage aneurysms effectively, thereby expanding the market for same.

Increased product developmental activities by market players worldwide is also slated to witness market growth for intracranial aneurysms. For example, in June 2022, Medtronic announced the launch of CE marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms.

Additionally, in September 2023, The Brain Aneurysm Foundation announced the launch of 'Stop the Pop', a new campaign intended to increase awareness of the prevalence and impact of brain aneurysms, and the need for ongoing investment to fund new innovations, screening, and treatment.

Therefore, all the factors stated above collectively will drive the overall intracranial aneurysms market growth.

However, stringent regulatory approval processes, complications associated with intracranial aneurysm treatment devices, and others may prove to be challenging factors for the intracranial aneurysms market growth.

Intracranial Aneurysms Market Segment Analysis:

Intracranial Aneurysms Market by Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, and Others), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of intracranial aneurysms, the embolization coils category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various key features of embolization coils that enhance their utility and effectiveness.

Embolization coils are critical in the minimally invasive treatment of intracranial aneurysms, offering key features such as high flexibility and visibility under X-ray, which ensure precise placement within the aneurysm. Typically made of platinum, these coils expand to fill the aneurysm sac, inducing clot formation and reducing the risk of rupture. Some coils are coated with bioactive or hydrogel materials to enhance clotting and healing within the aneurysm.

Embolization coils are primarily used for aneurysm occlusion, preventing blood flow into the aneurysm to reduce rupture risk. These are effective for small saccular and wide-necked aneurysms, and in complex cases, they may be used with adjunctive devices like stents or flow diverters to enhance treatment outcomes.

Furthermore, companies raising funds for the development and commercialization of the development of embolic coils are also expected to contribute to the segmental growth of the intracranial aneurysm market. For instance, in July 2021, a neuro- and peripheral-vascular interventional medical device company, Zylox-Tonbridge Medical Technology Co., Ltd. raised USD 329 million to aid the development and commercialization of its core products that include neurovascular embolization coils, a microcatheter for coiling, and others.

Therefore, the widespread uses and various key features of embolization coils that enhance performance and usability are solidifying the impact on the growth of the overall intracranial aneurysms market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall intracranial aneurysms market:

Among all the regions, North America is expected to dominate the intracranial aneurysms market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of brain aneurysm, combined with significant advancements in product development & regulatory approvals, presence of market key players, and availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the intracranial aneurysms market in the North America region during the forecast period from 2024 to 2030.

According to recent updated data from the Brain Aneurysm Foundation, stated that currently approximately 6.8 million individuals are affected by the brain aneurysm in the US. Further it added that, about 30,000 people in the US suffers brain aneurysm rupture each year. This condition is more prevalent in the individuals of aged from 35 to 60.

Since the cases of brain aneurysms is rising among middle-aged individuals the demand for more effective diagnostic and treatment options is increasing significantly. This trend is fueling investment in innovative technologies and expanding the market for the intracranial aneurysms.

Rising product developmental activities by market players in the region will further boost the market for intracranial aneurysms. For example, in June 2024, subsidiary of Terumo Corporation (Micro Vention), announced the US launch for its LVIS EVO intraluminal support device. The device is available in the US for the treatment of wide-neck intracranial aneurysms.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional intracranial aneurysms market growth. The presence of key players such as Johnson & Johnson Services, Inc., Medtronic, and Boston Scientific Corporation with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American intracranial aneurysms market.

Intracranial Aneurysms Market key players:

Some of the key market players operating in the intracranial aneurysms market include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical, Shape Memory Medical Inc, Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd, Lepu Medical Technology Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd, KANEKA CORPORATION, and others.

Recent Developmental Activities in the Intracranial Aneurysms Market:

  • In June 2024, Softek Illuminate, Inc., provider of enterprise follow-up management and discovery software, announced a new partnership with Wellstar, one of the largest health systems in Georgia, to launch the new Discovery360 Cerebral Aneurysm (CA) program.
  • In June 2024, Medtronic announced the European launch of Artisse, a new intrasaccular device designed to treat intracranial aneurysms by conforming to the shape of the aneurysm.

Key Takeaways from the Intracranial Aneurysms Market Report Study

  • Market size analysis for current intracranial aneurysms market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the intracranial aneurysms market.
  • Various opportunities available for the other competitors in the intracranial aneurysms market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current intracranial aneurysms market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Intracranial Aneurysms Market Report Study

  • Intracranial aneurysms product providers
  • Research organizations and consulting companies
  • Intracranial aneurysms-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in intracranial aneurysms
  • Various end-users who want to know more about the intracranial aneurysms market and the latest technological developments in the intracranial aneurysms market.

Frequently Asked Questions for the Intracranial Aneurysms Market:

1. What are intracranial aneurysms?

  • The intracranial aneurysms or a cerebral aneurysm is an abnormal focal dilation of a brain artery due to the weakening of the inner muscular layer of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning.

2. What is the market for intracranial aneurysms?

  • The intracranial aneurysms market was valued at USD 1.13 billion in 2023, growing at a CAGR of 9.10% during the forecast period from 2024 to 2030, to reach USD 1.90 billion by 2030.

3. What are the drivers for the intracranial aneurysms market?

  • The intracranial aneurysms market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as hypertension, innovative product developmental activities by leading companies, expanding geriatric population, and increasing government initiatives that are factors expected to escalate the overall growth of the intracranial aneurysms market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the intracranial aneurysms market?

  • Some of the key market players operating in intracranial aneurysms include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical, Shape Memory Medical Inc, Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co. Ltd, Lepu Medical Technology Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd, KANEKA CORPORATION, and others.

5. Which region has the highest share in the intracranial aneurysms market?

North America is expected to dominate the overall intracranial aneurysms market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high instances of brain aneurysm, combined with significant advancements in product development & regulatory approvals, presence of market key players, and availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the intracranial aneurysms market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Intracranial Aneurysms Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Intracranial Aneurysms Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Intracranial Aneurysms Market Key Factors Analysis

  • 5.1. Intracranial Aneurysms Market Drivers
    • 5.1.1. Increasing cases of chronic disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Increasing prevalence of lifestyle disorders
    • 5.1.4. Rising geriatric population
  • 5.2. Intracranial Aneurysms Market Restraints and Challenges
    • 5.2.1. The stringent regulatory approval process
    • 5.2.2. Complications associated with intracranial aneurysm treatment devices
  • 5.3. Intracranial Aneurysms Market Opportunities
    • 5.3.1. Research into bioresorbable materials for aneurysm treatment devices
    • 5.3.2. Strategic business activities by the global as well as regional manufacturers

6. Intracranial Aneurysms Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Intracranial Aneurysms Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Surgical Clippings
    • 7.1.2. Embolization Coils
    • 7.1.3. Flow Diverters
    • 7.1.4. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Intracranial Aneurysms Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Intracranial Aneurysms Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.3. India Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Intracranial Aneurysms Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Intracranial Aneurysms Market Size in USD million (2021-2030)

8. Intracranial Aneurysms Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. MicroPort Scientific Corporation.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. B. Braun Melsungen AG
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Stryker
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Johnson & Johnson Services, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Terumo Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Penumbra, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Balt
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Wallaby Medical
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Shape Memory Medical Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Zylox-Tonbridge Medical Technology Co., Ltd.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Spartan Micro, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Mizuho Medical Co. Ltd
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Lepu Medical Technology Co., Ltd.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Phenox GmbH
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Peter LAZIC GmbH
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. adeor medical AG
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Boston Scientific Corporation
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Meril Life Sciences Pvt. Ltd
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. KANEKA CORPORATION
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Intracranial Aneurysms Market in Global (2021-2030)
  • Table 3: Intracranial Aneurysms Market in Global by Product Type (2021-2030)
  • Table 4: Intracranial Aneurysms Market in Global by End-User (2021-2030)
  • Table 5: Intracranial Aneurysms Market in Global by Geography (2021-2030)
  • Table 6: Intracranial Aneurysms Market in North America (2021-2030)
  • Table 7: Intracranial Aneurysms Market in the United States (2021-2030)
  • Table 8: Intracranial Aneurysms Market in Canada (2021-2030)
  • Table 9: Intracranial Aneurysms Market in Mexico (2021-2030)
  • Table 10: Intracranial Aneurysms Market in Europe (2021-2030)
  • Table 11: Intracranial Aneurysms Market in France (2021-2030)
  • Table 12: Intracranial Aneurysms Market in Germany (2021-2030)
  • Table 13: Intracranial Aneurysms Market in United Kingdom (2021-2030)
  • Table 14: Intracranial Aneurysms Market in Italy (2021-2030)
  • Table 15: Intracranial Aneurysms Market in Spain (2021-2030)
  • Table 16: Intracranial Aneurysms Market in the Rest of Europe (2021-2030)
  • Table 17: Intracranial Aneurysms Market in Asia-Pacific (2021-2030)
  • Table 18: Intracranial Aneurysms Market in China (2021-2030)
  • Table 19: Intracranial Aneurysms Market in Japan (2021-2030)
  • Table 20: Intracranial Aneurysms Market in India (2021-2030)
  • Table 21: Intracranial Aneurysms Market in Australia (2021-2030)
  • Table 22: Intracranial Aneurysms Market in South Korea (2021-2030)
  • Table 23: Intracranial Aneurysms Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Intracranial Aneurysms Market in the Rest of the World (2021-2030)
  • Table 25: Intracranial Aneurysms Market in the Middle East (2021-2030)
  • Table 26: Intracranial Aneurysms Market in Africa (2021-2030)
  • Table 27: Intracranial Aneurysms Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Intracranial Aneurysms Market in Global (2021-2030)
  • Figure 3: Intracranial Aneurysms Market in Global by Product Type (2021-2030)
  • Figure 4: Intracranial Aneurysms Market in Global by End-User (2021-2030)
  • Figure 5: Intracranial Aneurysms Market in Global by Geography (2021-2030)
  • Figure 6: Intracranial Aneurysms Market in North America (2021-2030)
  • Figure 7: Intracranial Aneurysms Market in the United States (2021-2030)
  • Figure 8: Intracranial Aneurysms Market in Canada (2021-2030)
  • Figure 9: Intracranial Aneurysms Market in Mexico (2021-2030)
  • Figure 10: Intracranial Aneurysms Market in Europe (2021-2030)
  • Figure 11: Intracranial Aneurysms Market in France (2021-2030)
  • Figure 12: Intracranial Aneurysms Market in Germany (2021-2030)
  • Figure 13: Intracranial Aneurysms Market in United Kingdom (2021-2030)
  • Figure 14: Intracranial Aneurysms Market in Italy (2021-2030)
  • Figure 15: Intracranial Aneurysms Market in Spain (2021-2030)
  • Figure 16: Intracranial Aneurysms Market in the Rest of Europe (2021-2030)
  • Figure 17: Intracranial Aneurysms Market in Asia-Pacific (2021-2030)
  • Figure 18: Intracranial Aneurysms Market in China (2021-2030)
  • Figure 19: Intracranial Aneurysms Market in Japan (2021-2030)
  • Figure 20: Intracranial Aneurysms Market in India (2021-2030)
  • Figure 21: Intracranial Aneurysms Market in Australia (2021-2030)
  • Figure 22: Intracranial Aneurysms Market in South Korea (2021-2030)
  • Figure 23: Intracranial Aneurysms Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Intracranial Aneurysms Market in the Rest of the World (2021-2030)
  • Figure 25: Intracranial Aneurysms Market in the Middle East (2021-2030)
  • Figure 26: Intracranial Aneurysms Market in Africa (2021-2030)
  • Figure 27: Intracranial Aneurysms Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis